Clinical Trial Update: Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the accuracy, reliability and safety of GlucoMen®Day, a next-generation microdialysis continuous glucose monitor, in individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GlucoMen®Day

Snippet

Sponsor: Medical University of Graz | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED